Clinical Trials, Regulation

The New ICH-GCP Revision 2016

By Creative Pharma Services

Since 1996, ICH-GCP has set the international standards for the design, conduct and reporting of clinical trials.

In July 2015, the International Conference for Harmonization (ICH) released a draft open for discussion with a deadline on the 31 January 2016 (mainly for EU and US). The new draft includes 26 new points of change pertaining definitions, source documentation process, Investigator’s responsibilities, Sponsor’s responsibilities, as well as changes in handling and processing of Essential Documents of Clinical Trials.

The present article aims to uncover these new points and will attempt to conceptualize how the implementation of this new ICH-GCP update will affect the conduct of Clinical Trials in national, European and Global level.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.